| Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19 A Soleimani, S Kazemian, S Karbalai Saleh, A Aminorroaya, Z Shajari, ... American Journal of Hypertension 33 (12), 1102-1111, 2020 | 54 | 2020 |
| Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents S Baniasadi, M Habibi, R Haghgoo, MK Gamishan, F Dabaghzadeh, ... Iranian journal of pharmaceutical research: IJPR 13 (1), 291, 2014 | 47 | 2014 |
| A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19 A Sahebnasagh, M Mojtahedzadeh, F Najmeddin, A Najafi, M Safdari, ... Archives of medical research 51 (7), 631-635, 2020 | 34 | 2020 |
| Evaluation of epithelial lining fluid concentration of amikacin in critically ill patients with ventilator-associated pneumonia F Najmeddin, B Shahrami, S Azadbakht, M Dianatkhah, MR Rouini, ... Journal of intensive care medicine 35 (4), 400-404, 2020 | 34 | 2020 |
| Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit M Dianatkhah, A Najafi, M Sharifzadeh, A Ahmadi, H Sharifnia, ... Journal of research in pharmacy practice 6 (3), 173-177, 2017 | 32 | 2017 |
| Effects of renin–angiotensin–aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: a randomized triple-blind clinical trial F Najmeddin, M Solhjoo, H Ashraf, M Salehi, F Rasooli, M Ghoghaei, ... American journal of hypertension 34 (11), 1217-1226, 2021 | 29 | 2021 |
| High-dose amikacin for achieving serum target levels in critically ill elderly patients K Sadeghi, H Hamishehkar, F Najmeddin, A Ahmadi, E Hazrati, ... Infection and drug resistance, 223-228, 2018 | 28 | 2018 |
| Achievement of vancomycin therapeutic goals in critically ill patients: early individualization may be beneficial B Shahrami, F Najmeddin, S Mousavi, A Ahmadi, MR Rouini, K Sadeghi, ... Critical care research and practice 2016, 2016 | 28 | 2016 |
| Interferon beta-1a as a candidate for COVID-19 treatment; an open-label single-arm clinical trial P Payandemehr, M Azhdarzadeh, H Bahrami-Motlagh, A Hadadi, ... Frontiers in Emergency Medicine 4 (2s), e51-e51, 2020 | 23 | 2020 |
| Antibiotic therapy in sepsis: No next time for a second chance! B Shahrami, M Sharif, A Sefidani Forough, F Najmeddin, AA Arabzadeh, ... Journal of Clinical Pharmacy & Therapeutics 46 (4), 2021 | 18 | 2021 |
| Anticoagulant utilization evaluation in a teaching hospital: a prospective study H Khalili, S Dashti-Khavidaki, AHH Talasaz, F Najmedin, R Hosseinpoor Journal of pharmacy practice 23 (6), 579-584, 2010 | 18 | 2010 |
| The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients A Najafi, M Mojtahedzadeh, KH Ahmadi, M Abdollahi, M Mousavi, ... DARU Journal of Pharmaceutical Sciences 22, 1-9, 2014 | 17 | 2014 |
| A probable clinically significant interaction between warfarin and cloxacillin: three case reports H Khalili, N Nikvarz, F Najmeddin, S Dashti-Khavidaki European journal of clinical pharmacology 69, 721-724, 2013 | 17 | 2013 |
| Clinical significance of prognostic nutrition index in hospitalized patients with COVID‐19: results from single‐center experience with systematic review and meta‐analysis S Rashedi, M Keykhaei, M Pazoki, H Ashraf, A Najafi, S Kafan, N Peirovi, ... Nutrition in Clinical Practice 36 (5), 970-983, 2021 | 16 | 2021 |
| Administration of higher doses of amikacin in early stages of sepsis in critically ill patients F Najmeddin, A Ahmadi, L Mahmoudi, K Sadeghi, H Khalili, ... Acta Medica Iranica, 703-709, 2014 | 13 | 2014 |
| Prevalence of the insulin receptor substrate-1 (IRS-1) Gly972Arg and the insulin receptor substrate-2 (IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy … B Rashidi, L Azizy, F Najmeddin, E Azizi Journal of assisted reproduction and genetics 29, 195-201, 2012 | 13 | 2012 |
| Evaluation of amikacin pharmacokinetics in critically ill patients with intra-abdominal sepsis B Shahrami, F Najmeddin, MR Rouini, A Najafi, K Sadeghi, S Amini, ... Advanced Pharmaceutical Bulletin 10 (1), 114, 2020 | 10 | 2020 |
| Barriers to pharmaceutical care in Iran K Gholami, F Najmeddin Journal of Pharmaceutical Care, 39-40, 2013 | 10 | 2013 |
| Area under the curve-based dosing of vancomycin in critically ill patients using 6-hour urine creatinine clearance measurement B Shahrami, F Najmeddin, S Ghaffari, A Najafi, MR Rouini, ... Critical Care Research and Practice 2020, 2020 | 9 | 2020 |
| Corticosteroids administration following COVID-19-induced acute respiratory distress syndrome. Is it harmful or life-saving? S Azimi, A Sahebnasagh, H Sharifnia, F Najmeddin Frontiers in emergency medicine 4 (2s), e43-e43, 2020 | 8 | 2020 |
Dr.Mojtaba MojtahedzadehTehran University Medical Sciences/Sina HospitalVerified email at sina.tums.ac.ir
